[Methodic and clinical experience in anticoagulant therapy]. 1954

H RUNGE, and I HARTERT

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

H RUNGE, and I HARTERT
December 1954, Journal of the American Medical Women's Association,
H RUNGE, and I HARTERT
November 1962, Bulletin - Geisinger Medical Center,
H RUNGE, and I HARTERT
January 1970, British medical journal,
H RUNGE, and I HARTERT
April 1957, Minerva medica,
H RUNGE, and I HARTERT
March 1958, Canadian Medical Association journal,
H RUNGE, and I HARTERT
December 1951, Gaceta medica de Mexico,
H RUNGE, and I HARTERT
December 1950, Revista medica de Chile,
H RUNGE, and I HARTERT
January 1973, Acta chirurgiae plasticae,
Copied contents to your clipboard!